Perrigo Company plc – NYSE:PRGO
Perrigo Company stock price today
$23.8
-1.78
-6.99%
Financial Health
0
1
2
3
4
5
6
7
8
9
Market closed
Open in 2 days
Perrigo Company stock price monthly change
-6.88%
month
Perrigo Company stock price quarterly change
-6.88%
quarter
Perrigo Company stock price yearly change
-20.16%
year
Perrigo Company key metrics
Market Cap | 3.50B |
Enterprise value | 6.78B |
P/E | -22.71 |
EV/Sales | 1.54 |
EV/EBITDA | 24.63 |
Price/Sales | 0.79 |
Price/Book | 0.77 |
PEG ratio | -2.44 |
EPS | -0.03 |
Revenue | 4.55B |
EBITDA | 633.7M |
Income | -5.60M |
Revenue Q/Q | -8.41% |
Revenue Y/Y | -0.06% |
Profit margin | -3.53% |
Oper. margin | 3.49% |
Gross margin | 36.08% |
EBIT margin | 3.49% |
EBITDA margin | 13.91% |
Sign up &
create your own Smart Feed
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freePerrigo Company stock price history
Perrigo Company stock forecast
Perrigo Company financial statements
| Jul 2023 | 1.19B | 8.4M | 0.7% |
|---|---|---|---|
| Sep 2023 | 1.12B | 14.2M | 1.26% |
| Dec 2023 | 1.15B | -32.3M | -2.79% |
| Mar 2024 | 1.08B | 4.09M | 0.38% |
| Sep 2025 | 1.21B | 114.20M | 9.4% |
|---|---|---|---|
| Dec 2025 | 1.27B | 125.21M | 9.86% |
| Dec 2025 | 1.26B | 126.01M | 9.97% |
| Mar 2026 | 1.19B | 115.58M | 9.66% |
Analysts Price target
Financials & Ratios estimates
| 2022-11-08 | 0.651 | 0.56 |
|---|---|---|
| 2022-12-31 | -0.20806 | -0.21561 |
| 2023-02-27 | 0.702 | 0.75 |
Paying a dividend while loss making.
4.31%
Yield TTM
| Payout ratio | -97.16% |
|---|
| 2019 | 1.6% |
|---|---|
| 2020 | 2.04% |
| 2021 | 2.49% |
| 2022 | 3.11% |
| 2023 | 3.44% |
| Jul 2023 | 10964700000 | 6.11B | 55.78% |
|---|---|---|---|
| Sep 2023 | 10758300000 | 6.02B | 55.96% |
| Dec 2023 | 10809100000 | 6.04B | 55.89% |
| Mar 2024 | 10640300000 | 5.95B | 55.95% |
| Jul 2023 | 52.9M | -4.4M | -48.6M |
|---|---|---|---|
| Sep 2023 | 124.5M | -30.7M | -43.3M |
| Dec 2023 | 208.7M | -22.8M | -44.6M |
| Mar 2024 | -1.4M | -23.5M | -60.4M |
Perrigo Company alternative data
| Aug 2023 | 8,900 |
|---|---|
| Sep 2023 | 8,900 |
| Oct 2023 | 8,900 |
| Nov 2023 | 8,900 |
| Dec 2023 | 8,900 |
| Jan 2024 | 8,900 |
| Feb 2024 | 8,900 |
| Mar 2024 | 9,140 |
| Apr 2024 | 9,140 |
| May 2024 | 9,140 |
| Jun 2024 | 9,140 |
| Jul 2024 | 9,140 |
Perrigo Company other data
98.20%
+4.94%
of PRGO is owned by hedge funds
307
+2
131.19M
+6.41M
shares is hold by hedge funds
What is insider trading?
| Period | Buy | Sel |
|---|---|---|
| Feb 2024 | 17045 | 0 |
| Mar 2024 | 2861 | 0 |
| May 2024 | 1000 | 0 |
| Dec 2024 | 0 | 17598 |
| Transaction | Date | Insider | Security | Shares | Price per share | Total value | Source |
|---|---|---|---|---|---|---|---|
Sale | KINDLER JEFFREY B director | Ordinary Shares | 17,598 | $28.27 | $497,495 | ||
Option | BEZERRA EDUARDO GUARITA officer: EVP & Ch.. | Ordinary Shares | 4,532 | $26.94 | $122,092 | ||
Option | BEZERRA EDUARDO GUARITA officer: EVP & Ch.. | Restricted Stock Units | 4,532 | N/A | N/A | ||
Purchase | ANDERSEN SVEND officer: EVP & Pr.. | Ordinary Shares | 1,000 | $27.9 | $27,900 | ||
Purchase | ANDERSEN SVEND officer: EVP & Pr.. | Ordinary Shares | 1,000 | $27.9 | $27,900 | ||
Option | ALFORD BRADLEY A director | Ordinary Shares | 8,764 | $30.22 | $264,848 | ||
Option | MANZONE ALBERT director | Ordinary Shares | 8,764 | $30.22 | $264,848 | ||
Option | MANZONE ALBERT director | Restricted Stock Units | 8,764 | N/A | N/A | ||
Option | PARKER GEOFFREY M. director | Ordinary Shares | 8,764 | $30.22 | $264,848 | ||
Option | PARKER GEOFFREY M. director | Restricted Stock Units | 8,764 | N/A | N/A |
| Quarter | Transcript |
|---|---|
| Q1 2024 7 May 2024 | Q1 2024 Earnings Call Transcript |
| Q4 2023 27 Feb 2024 | Q4 2023 Earnings Call Transcript |
| Q3 2023 7 Nov 2023 | Q3 2023 Earnings Call Transcript |
| Q2 2023 8 Aug 2023 | Q2 2023 Earnings Call Transcript |
Trump's Tariffs Circle Pharma Industry: Who It Affects And How It May Play Out
Perrigo Paves The Way For Recovery With Margin Focus
Perrigo's New Chapter: Its Bold Turnaround Plan Is Worth Buying
The Prognosis For Perrigo
Perrigo Company: Still Not Getting There
Perrigo Company plc Is Back On Track
Perrigo: HRA Acquisition To Drive Significant Growth
Perrigo: Honing In On A Long Term Bottom
BioLineRx: A Top Candidate For A Takeover Before 2022 Ends
-
What's the price of Perrigo Company stock today?
One share of Perrigo Company stock can currently be purchased for approximately $23.8.
-
When is Perrigo Company's next earnings date?
Unfortunately, Perrigo Company's (PRGO) next earnings date is currently unknown.
-
Does Perrigo Company pay dividends?
Yes, Perrigo Company pays dividends and its trailing 12-month yield is 4.31% with -97% payout ratio.It means that the company is paying a dividend while loss making. The last Perrigo Company stock dividend of $0.24 was paid on 21 Dec 2021.
-
How much money does Perrigo Company make?
Perrigo Company has a market capitalization of 3.50B and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 4.58% to 4.66B US dollars. Perrigo Company made a loss 12.7M US dollars in net income (profit) last year or $0.75 on an earnings per share basis.
-
What is Perrigo Company's stock symbol?
Perrigo Company plc is traded on the NYSE under the ticker symbol "PRGO".
-
What is Perrigo Company's primary industry?
Company operates in the Healthcare sector and Drug Manufacturers - Specialty & Generic industry.
-
How do i buy shares of Perrigo Company?
Shares of Perrigo Company can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
Who are Perrigo Company's key executives?
Perrigo Company's management team includes the following people:
- Mr. Murray S. Kessler Chief Executive Officer, Pres & Director(age: 65, pay: $3,220,000)
- Mr. Raymond P. Silcock Chief Financial Officer, Principal Accounting Officer & Executive Vice President(age: 74, pay: $1,360,000)
- Mr. Svend Andersen Executive Vice President & Pres of Consumer Healthcare International(age: 63, pay: $1,120,000)
- Mr. Richard S. Sorota Executive Vice President & Pres of Consumer Self-Care Americas(age: 62, pay: $1,100,000)
- Mr. Todd W. Kingma Executive Vice President, Gen. Counsel & Sec.(age: 65, pay: $1,100,000)
-
How many employees does Perrigo Company have?
As Jul 2024, Perrigo Company employs 9,140 workers.
-
When Perrigo Company went public?
Perrigo Company plc is publicly traded company for more then 33 years since IPO on 17 Dec 1991.
-
What is Perrigo Company's official website?
The official website for Perrigo Company is perrigo.com.
-
How can i contact Perrigo Company?
Perrigo Company can be reached via phone at +353 1 709 4000.
Perrigo Company company profile:
Perrigo Company plc
perrigo.comExchange:
NYSE
Full time employees:
9,140
Industry:
Drug Manufacturers - Specialty & Generic
Sector:
Healthcare
Perrigo Company plc provides over-the-counter (OTC) health and wellness solutions that enhance individual well-being by empowering consumers to prevent or treat conditions that can be self-managed. The company operates through two segments, Consumer Self-Care Americas and Consumer Self-Care International. The Consumer Self-Care Americas segment focuses primarily on the development, manufacture, marketing, and sale of store brand, self-care products in categories, including upper respiratory, pain and sleep-aids, digestive health, nutrition, vitamins, minerals and supplements, healthy lifestyle, skincare and personal hygiene, and oral self-care in the United States, Mexico, Canada, and South America. The segment offers its products under the Prevacid 24HR, Good Sense, Zephrex D, ScarAway, Plackers, Rembrandt, Steripod, Firefly, REACH, Dr. Fresh, and Burt's Bees brand names. The Consumer Self-Care International segment develops, manufactures, markets, and distributes consumer self-care brands through a network of pharmacies, wholesalers, drug and grocery store retailers, and para-pharmacies in approximately 23 countries, primarily in Europe. The company also offers contract manufacturing services. Perrigo Company plc was founded in 1887 and is headquartered in Dublin, Ireland.
The Sharp Building
Dublin, 2
Dublin, 2
CIK: 0001585364
ISIN: IE00BGH1M568
CUSIP: G97822103
